MCL-1 protein abundance is the product of a series of upstream events, which may also be perturbed in breast cancer, such that quantification of MCL1 gene and mRNA copy number levels may underestimate the extent to which MCL-1 is upregulated [44]. This evidence concerns the gene MCL1 and breast carcinoma.